Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Injection molding method and injection molding machine
Automatic population of feature capabilities on a communication device
Solid-state imaging device and electronic apparatus with antireflection structure
Drug comprising as the active ingredient proliferative vector containing survivin promoter
Mobile device case with storage compartment
Demand based power allocation
  Randomly Featured Patents
Spacecraft TDMA communications system with synchronization by spread spectrum overlay channel
Communication interface circuit, electronic device, and communication method
Pressureless sintered body of boron nitride
Mechanism for regulating collapsible elements
Vapor permeation curable coatings for reaction injection molded parts
Laparoscopic implantation of neurostimulators
Aluminum surface cleaning agent
Shell tile thermal protection system
Difraction grating having enhanced blaze performance at two wavelengths
Sheet material dispenser